Cancer mRNA vaccine completes pivotal trial

Cancer mRNA vaccine completes pivotal trial Researchers say they have successfully completed a trial of a personalised cancer vaccine that uses the same messenger-RNA technology as Covid jabs.

The experimental vaccine, made by Moderna and MSD, is designed to prime the immune system to seek and destroy cancerous cells.

Doctors hope work such as this could lead to revolutionary new ways to fight skin, bowel and other types of cancer.

Moderna and MSD called it "a new paradigm" moment. BBC News

See also:

• Moderna and Merck announce mrna-4157/v940, an investigational personalized mrna cancer vaccine, in combination with keytruda(r) (pembrolizumab), met primary efficacy endpoint in phase 2b keynote-942 trial Moderna
• 'New paradigm' moment as mRNA cancer vaccine slashes risk of tumor relapse or death The Daily Mail
• Positive Moderna, Merck cancer vaccine data advances mRNA promise Reuters